Ningbo Bohui Chemical Technology Co.,Ltd (SHE:300839)
China · Delayed Price · Currency is CNY 12.40
+0.13 (1.06%)
At close: Feb 6, 2026
SHE:300839 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,787 | 2,266 | 2,660 | 2,825 | 1,714 | 800.74 |
Other Revenue | 13.08 | 13.08 | 117.98 | 140.4 | 0.3 | 171.55 |
| 2,800 | 2,279 | 2,778 | 2,965 | 1,714 | 972.29 | |
Revenue Growth (YoY) | 17.37% | -17.94% | -6.32% | 72.96% | 76.32% | 17.54% |
Cost of Revenue | 2,771 | 1,946 | 2,569 | 2,623 | 1,578 | 806.47 |
Gross Profit | 28.8 | 333.65 | 208.83 | 341.82 | 136.21 | 165.81 |
Selling, General & Admin | 62.93 | 71.92 | 59.54 | 47.58 | 32.13 | 34.32 |
Research & Development | 34.97 | 60.56 | 62.94 | 75.28 | 30.76 | 34.11 |
Other Operating Expenses | 62.01 | 389.53 | 140.73 | 29.66 | 17.74 | 21.6 |
Operating Expenses | 153.38 | 521.97 | 263.2 | 152.55 | 80.63 | 90.01 |
Operating Income | -124.58 | -188.31 | -54.37 | 189.27 | 55.58 | 75.8 |
Interest Expense | -47.18 | -51.91 | -41.53 | -33.54 | -23.16 | -11.08 |
Interest & Investment Income | 53.46 | 15.59 | 4.04 | 8.15 | 0.66 | 1.07 |
Currency Exchange Gain (Loss) | 0.69 | 0.69 | 4.27 | -10.64 | 0.01 | -0.07 |
Other Non Operating Income (Expenses) | -9.07 | -2.4 | -36.73 | -0.25 | -3.64 | -7.64 |
EBT Excluding Unusual Items | -126.69 | -226.34 | -124.33 | 153 | 29.45 | 58.08 |
Gain (Loss) on Sale of Investments | 4.01 | -4.03 | -8.75 | 5.1 | - | - |
Gain (Loss) on Sale of Assets | 13.36 | 0.07 | 0.01 | 0.02 | 0.04 | - |
Asset Writedown | -81.87 | -65.47 | -62.89 | -0 | -0.02 | - |
Other Unusual Items | -2.82 | 1.33 | 5.92 | 3.44 | 0.5 | 8.82 |
Pretax Income | -194.01 | -294.44 | -190.03 | 161.56 | 29.96 | 66.9 |
Income Tax Expense | 18.39 | 15.46 | 12.92 | 9.79 | -0.07 | 9.11 |
Earnings From Continuing Operations | -212.4 | -309.9 | -202.95 | 151.77 | 30.03 | 57.79 |
Minority Interest in Earnings | 1.89 | 3.08 | - | - | - | - |
Net Income | -210.5 | -306.82 | -202.95 | 151.77 | 30.03 | 57.79 |
Net Income to Common | -210.5 | -306.82 | -202.95 | 151.77 | 30.03 | 57.79 |
Net Income Growth | - | - | - | 405.37% | -48.04% | -23.69% |
Shares Outstanding (Basic) | 246 | 240 | 245 | 245 | 247 | 215 |
Shares Outstanding (Diluted) | 246 | 240 | 245 | 245 | 247 | 215 |
Shares Change (YoY) | 2.23% | -1.97% | -0.11% | -1.04% | 15.23% | 16.23% |
EPS (Basic) | -0.86 | -1.28 | -0.83 | 0.62 | 0.12 | 0.27 |
EPS (Diluted) | -0.86 | -1.28 | -0.83 | 0.62 | 0.12 | 0.27 |
EPS Growth | - | - | - | 410.71% | -54.90% | -34.34% |
Free Cash Flow | -524.52 | -353.75 | 310.64 | -22.21 | -57.67 | -286.37 |
Free Cash Flow Per Share | -2.13 | -1.48 | 1.27 | -0.09 | -0.23 | -1.33 |
Dividend Per Share | - | - | - | 0.086 | 0.044 | 0.169 |
Dividend Growth | - | - | - | 95.22% | -74.04% | 33.36% |
Gross Margin | 1.03% | 14.64% | 7.52% | 11.53% | 7.95% | 17.05% |
Operating Margin | -4.45% | -8.26% | -1.96% | 6.38% | 3.24% | 7.80% |
Profit Margin | -7.52% | -13.46% | -7.31% | 5.12% | 1.75% | 5.94% |
Free Cash Flow Margin | -18.73% | -15.52% | 11.18% | -0.75% | -3.36% | -29.45% |
EBITDA | -3.95 | -78.5 | 41.03 | 275.52 | 100.57 | 84.65 |
EBITDA Margin | -0.14% | -3.44% | 1.48% | 9.29% | 5.87% | 8.71% |
D&A For EBITDA | 120.63 | 109.82 | 95.41 | 86.25 | 44.99 | 8.84 |
EBIT | -124.58 | -188.31 | -54.37 | 189.27 | 55.58 | 75.8 |
EBIT Margin | -4.45% | -8.26% | -1.96% | 6.38% | 3.24% | 7.80% |
Effective Tax Rate | - | - | - | 6.06% | - | 13.61% |
Revenue as Reported | 2,800 | 2,279 | 2,778 | 2,965 | 1,714 | 972.29 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.